Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro

Author： Donald Sarah   Verschoyle Richard   Greaves Peter   Orr Samantha   Jimeno Jose   Gescher Andreas  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.53, Iss.4, 2004-04, pp. : 305-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin): An example of potential problems for extrapolation of active drug concentrations from in vitro studies

By Tognon Gianluca   Frapolli Roberta   Zaffaroni Marco   Erba Eugenio   Zucchetti Massimo   Faircloth Glynn   D’Incalci Maurizio  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 89-90

Springer Publishing Company

Access to resources Recommend Favorite

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer

By Beumer Jan   Rademaker-Lakhai Jeany   Rosing Hilde   Hillebrand Michel   Bosch Tessa   Lopez-Lazaro Luis   Schellens Jan   Beijnen Jos  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 825-837

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of Yondelis(TM) (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

By Twelves C.   Hoekman K.   Bowman A.   Vermorken J.B.   Anthoney A.   Smyth J.   van Kesteren C.   Beijnen J.H.   Uiters J.   Wanders J.   Gomez J.   Guzman C.   Jimeno J.   Hanauske A.   for the New Drug Development Group of the EORTC  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1842-1851

Elsevier

Access to resources Recommend Favorite

In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors - comparison with the clinical results

By Albella B.   Faircloth G.   Lopez-Lazaro L.   Guzman C.   Jimeno J.   Bueren J.A.  

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1395-1404

Elsevier

Access to resources Recommend Favorite

Editorial comment on ''In vitro toxicity of ET-743 and Aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: comparison with the clinical results'' by Albella and colleagues

By D'Incalci M.  

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1297-1297

Elsevier

Access to resources Recommend Favorite